Status:

COMPLETED

Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial

Lead Sponsor:

University of Sao Paulo

Collaborating Sponsors:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Brain & Behavior Research Foundation

Conditions:

Major Depressive Disorder

Major Depressive Disorder, Recurrent, Unspecified

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Major depressive disorder (MDD) is a common psychiatric condition, mostly treated with antidepressant drugs, which are limited for issues such as refractoriness and adverse effects. In this context, t...

Detailed Description

Major depressive disorder (MDD) is a common psychiatric condition, mostly treated with antidepressant drugs, which are limited for issues such as refractoriness and adverse effects. In this context, t...

Eligibility Criteria

Inclusion

  • HAMD17\>=17
  • more than 8 years of schooling OR able to read, speak and understand the Portuguese language.
  • Low suicide risk.

Exclusion

  • Bipolar disorders.
  • Schizophrenia and other psychotic disorders.
  • Anxiety disorders, if it is the primary diagnosis (comorbidity with depression is not an exclusion disorder)
  • Substance abuse or dependence.
  • Depression symptoms better explained by medical conditions.
  • Neurologic conditions (e.g., stroke, multiple sclerosis, brain tumor).
  • Severe medical conditions.
  • Pregnancy/breast-feeding.
  • Severe suicidal ideation, suicidal planning or recent (\<4 weeks) suicide attempt.
  • Contra-indications to escitalopram.
  • Current use of escitalopram in the current depressive episode.
  • Use of escitalopram in a prior depressive episode that was not effective.
  • Contra-indications to tDCS.
  • Previous use of tDCS (current or previous depressive episode).

Key Trial Info

Start Date :

October 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2016

Estimated Enrollment :

245 Patients enrolled

Trial Details

Trial ID

NCT01894815

Start Date

October 1 2013

End Date

November 1 2016

Last Update

December 5 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Universitário, Universidade de São Paulo

São Paulo, São Paulo, Brazil, 05508-000

2

Institute of Psychiatry, HC-FMUSP

São Paulo, São Paulo, Brazil

Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial | DecenTrialz